THE SMALL AND MEDIUM – SIZED ENTERPRISE (SME) “POLYGENE AG” IS INTERESTED IN GETTING INVOLVED IN CONSORTIA FOR HORIZON 2020 HEALTH, DEMOGRAPHIC CHANGE AND WELLBEING
“Polygene” is a transgenic service providing SME, based in Switzerland that is looking for consortia participating in the following topics within the Work Programme 2014-2015 health, demographic change and wellbeing and might want to involve an SME partner in their projects:
- PHC 1 – 2014: Understanding health, ageing and disease: determinants, risk factors and pathways
- PHC 2 – 2015: Understanding diseases: systems medicine
- PHC 3 – 2015: Understanding common mechanisms of diseases and their relevance in co-morbidities
- PHC 11 – 2015: Development of new diagnostic tools and technologies: in vivo medical imaging technologies
- PHC 14 -2015: New therapies for rare diseases
The SMEs expertise lies in the generation of genetically modified animals, e.g. for target validation studies. R&D endeavours include improvement of sequence nuclease based genome engineering technologies and the improvement of currently available inducible expression systems for in-vivo studies.
If you are interested please contact Stefan Selbert at stefan.selbert@polygene.ch
